HSCSW

Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 1 9002 41900 4 319 Gross profit 1 1401 41100 2 551 Operating expenses 1.88 M2.07 M1.93 M2.54 M 8.42 M Selling/general/admin expenses 878.05 K1.35 M1.29 M2.06 M 5.58 M Research & development 997.21 K727.03 K638.58 K476.2 K 2.84 M Operating income -1.87 M-2.07 M-1.93 M-2.54 M -8.41 M Non-Operating Income, Total -180.88 K-277.37 K-56.27 K-214.5 K -729.01 K Interest expense, net of interest capitalized 183.69 K279.53 K61.51 K228.31 K 753.04 K Non-Operating Income, excl. Interest Expenses -180.88 K-277.37 K-61.51 K-228.31 K -748.06 K Unusual income/expense 2 8132 1685 24113.81 K 24.03 K Pretax income -2.24 M-2.63 M-2.05 M-2.98 M -9.89 M Equity in earnings ———— — Taxes ———-5 488 — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -2.05 M-2.35 M-1.99 M-2.75 M -9.14 M Discontinued operations ———— — Net income -2.05 M-2.35 M-1.99 M-2.75 M -9.14 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -2.05 M-2.35 M-1.99 M-2.75 M -9.14 M Basic earnings per share (Basic EPS) -1.58-0.85-0.63-0.42 -3.48 Diluted earnings per share (Diluted EPS) -1.58-0.85-0.63-1.05 -4.11 Average basic shares outstanding 1.3 M2.78 M3.16 M2.63 M — Diluted shares outstanding 1.3 M2.78 M3.16 M2.63 M — EBITDA -1.76 M-1.8 M-1.9 M-2.43 M -7.89 M EBIT -1.87 M-2.07 M-1.93 M-2.54 M -8.41 M Cost of revenue 7601 00800 1 768 Other cost of goods sold ———— — Depreciation & amortization (cash flow) 117.06 K270.89 K28.2 K107.59 K 523.74 K